Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Enfusion Inc Cl A (NY: ENFN )

8.850 +0.130 (+1.49%)
Streaming Delayed Price Updated: 9:54 AM EST, Nov 5, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Enfusion Inc Cl A

< Previous 1 2 Next >
Enfusion Announces Third Quarter 2024 Results
From Enfusion, Inc.
Via Business Wire
Enfusion Announces Key Leadership Team Additions to Drive Client Success and Fuel Innovation
From Enfusion, Inc.
Via Business Wire
Enfusion Announces Date of Third Quarter 2024 Results
From Enfusion, Inc.
Via Business Wire
ENFN Investors Have Opportunity to Join Enfusion, Inc. Securities Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
Enfusion, Inc. (ENFN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Enfusion, Inc. (ENFN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
ENFN Investors Have Opportunity to Join Enfusion, Inc. Securities Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
Enfusion Announces Second Quarter 2024 Results
From Enfusion, Inc.
Via Business Wire
Enfusion Introduces the Next Phase of Portfolio Workbench, Empowering Asset Managers with Increased Efficiency and Flexibility
From Enfusion, Inc.
Via Business Wire
Enfusion Announces Date of Second Quarter 2024 Results
From Enfusion, Inc.
Via Business Wire
Enfusion To Present at Upcoming Investor Events
From Enfusion, Inc.
Via Business Wire
Enfusion Announces First Quarter 2024 Results
From Enfusion, Inc.
Via Business Wire
Enfusion Announces Date of First Quarter 2024 Results
From Enfusion, Inc.
Via Business Wire
Kayne Anderson Strengthens Investment Operations After Successful Platform Migration to Enfusion
From Enfusion
Via Business Wire
Enfusion Announces Fourth Quarter 2023 Results and Full Year 2023 Results
From Enfusion, Inc.
Via Business Wire
Enfusion Announces Date of Fourth Quarter and Full Year 2023 Results
From Enfusion, Inc.
Via Business Wire
Enfusion to Host Investor Day on March 19, 2024
From Enfusion, Inc.
Via Business Wire
Enfusion Announces Appointment of Chief Operating Officer
From Enfusion, Inc.
Via Business Wire
Enfusion Announces Third Quarter 2023 Results
From Enfusion, Inc.
Via Business Wire
Enfusion Announces Date of Third Quarter 2023 Results
From Enfusion, Inc.
Via Business Wire
Enfusion Launches Portfolio Workbench, Empowering Portfolio Managers to Seamlessly Rebalance Multi-Asset Portfolios
From Enfusion, Inc.
Via Business Wire
Enfusion Announces Closing of New $100 Million Credit Facility
From Enfusion, Inc.
Via Business Wire
Enfusion Announces Second Quarter 2023 Results
From Enfusion, Inc.
Via Business Wire
Enfusion Announces Date of Second Quarter 2023 Results
From Enfusion, Inc.
Via Business Wire
Enfusion To Present at the 43rd Annual William Blair Growth Stock Conference
From Enfusion, Inc.
Via Business Wire
Enfusion Announces First Quarter 2023 Results
From Enfusion, Inc.
Via Business Wire
Enfusion Announces Date of First Quarter 2023 Results
From Enfusion, Inc.
Via Business Wire
Enfusion Announces Partnership With Leading Risk Management Provider Qontigo
From Enfusion, Inc.
Via Business Wire
Enfusion Announces Fourth Quarter 2022 Results and Full Year 2022 Results
From Enfusion, Inc.
Via Business Wire
Enfusion Announces Date of Fourth Quarter and Full Year 2022 Results
From Enfusion, Inc.
Via Business Wire
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.